Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial. (linkinghub.elsevier.com)

Authors: Shen Z … Hawkins MA Journal: EBioMedicine Published: 2026-07-27 DOI: https://doi.org/10.1016/j.ebiom.2026.106397